1. Home
  2. PROP vs PRPO Comparison

PROP vs PRPO Comparison

Compare PROP & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prairie Operating Co.

PROP

Prairie Operating Co.

N/A

Current Price

$0.31

Market Cap

44.9M

Sector

Finance

ML Signal

N/A

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$18.52

Market Cap

38.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PROP
PRPO
Founded
2001
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
44.9M
38.3M
IPO Year
2008
2000

Fundamental Metrics

Financial Performance
Metric
PROP
PRPO
Price
$0.31
$18.52
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $1.50
N/A
AVG Volume (30 Days)
★ 1.2M
23.9K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
49.06
★ 92.15
EPS
★ N/A
N/A
Revenue
$7,939,000.00
★ $24,049,000.00
Revenue This Year
$85.81
$233.72
Revenue Next Year
$11.47
$22.61
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 413.59
29.77
52 Week Low
$0.30
$17.79
52 Week High
$2.55
$33.63

Technical Indicators

Market Signals
Indicator
PROP
PRPO
Relative Strength Index (RSI) 36.77 42.45
Support Level N/A $18.51
Resistance Level $0.44 $24.89
Average True Range (ATR) 0.05 1.93
MACD -0.01 0.11
Stochastic Oscillator 2.94 20.66

Price Performance

Historical Comparison
PROP
PRPO

About PROP Prairie Operating Co.

Prairie Operating Co is an independent oil and natural gas company focused on the acquisition and development of crude oil, natural gas, and natural gas liquids (NGLs). Its assets and operations are located in the oil region of rural Weld County, Colorado, within the Denver-Julesburg Basin in Colorado (the DJ Basin). The company generates maximum revenue from crude oil sales, and the rest from the sale of natural gas and natural gas liquids.

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Share on Social Networks: